Polycythemia vera: Introduction
Polycythemia vera: A condition which is characterized by myeloproliferation of unknown etiology.
More detailed information about the symptoms,
causes, and treatments of Polycythemia vera is available below.
Symptoms of Polycythemia vera
See full list of 17
symptoms of Polycythemia vera
Home Diagnostic Testing
Home medical testing related to Polycythemia vera:
Wrongly Diagnosed with Polycythemia vera?
Polycythemia vera: Related Patient Stories
Polycythemia vera: Complications
Review possible medical complications related to Polycythemia vera:
Causes of Polycythemia vera
Read more about causes of Polycythemia vera.
Disease Topics Related To Polycythemia vera
Research the causes of these diseases that are similar to, or related to, Polycythemia vera:
Less Common Symptoms of Polycythemia vera
Read more about symptoms of Polycythemia vera
Misdiagnosis and Polycythemia vera
Unnecessary hysterectomies due to undiagnosed bleeding disorder in women: The bleeding disorder
called Von Willebrand's disease is quite common in women, but often fails to be correctly diagnosed...read more »
Read more about Misdiagnosis and Polycythemia vera
Polycythemia vera: Research Doctors & Specialists
Research related physicians and medical specialists:
Other doctor, physician and specialist research services:
Evidence Based Medicine Research for Polycythemia vera
Medical research articles related to Polycythemia vera include:
Click here to find more evidence-based articles on the TRIP Database
Polycythemia vera: Animations
More Polycythemia vera animations & videos
Research about Polycythemia vera
Visit our research pages for current research about Polycythemia vera treatments.
Clinical Trials for Polycythemia vera
The US based website ClinicalTrials.gov lists information on both federally
and privately supported clinical trials using human volunteers.
Some of the clinical trials listed on ClinicalTrials.gov for Polycythemia vera include:
- Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia - This study has been completed (Current: 23 Nov 2006) - busulfan,cytarabine,etoposide,filgrastim,fludarabine,isotretinoin,topotecan,vitamin E
- Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis - This study is no longer recruiting patients (Current: 23 Nov 2006) - bone marrow ablation with stem cell support,busulfan,cytarabine,filgrastim,idarubicin
- Therapy of HES, PV, Atypical CML or CMML With PDGF-R Fusion Genes, or Mastocytosis With Gleevec - This study is currently recruiting patients (Current: 23 Nov 2006) - Gleevec (imatinib mesylate)
- Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera - This study is no longer recruiting patients (Current: 23 Nov 2006) - pegylated interferon-alfa 2a
- Dasatinib as Therapy for Myeloproliferative Disorders (MPDs) - This study is currently recruiting patients (Current: 23 Nov 2006) - dasatinib (BMS-354825)
- more trials...»
See full list of 80
Clinical Trials for Polycythemia vera
Statistics for Polycythemia vera
Polycythemia vera: Broader Related Topics
Types of Polycythemia vera
User Interactive Forums
Read about other experiences, ask a question about Polycythemia vera, or answer someone else's question, on our message boards:
Definitions of Polycythemia vera:
Polycythemia vera is listed as a "rare disease" by the Office of
Rare Diseases (ORD) of the National Institutes of Health
(NIH). This means that Polycythemia vera, or a subtype of Polycythemia vera,
affects less than 200,000 people in the US population.
Source - National Institutes of Health (NIH)
Ophanet, a consortium of European partners,
currently defines a condition rare when it affects 1 person per 2,000.
They list Polycythemia vera as a "rare disease".
Source - Orphanet
Contents for Polycythemia vera:
» Next page: What is Polycythemia vera?
Medical Tools & Articles:
Tools & Services:
Forums & Message Boards
- Ask or answer a question at the Boards: